Chaplin DJ, Horsman MR Tumor blood flow changes induced by chemical modifiers of radiation response. Int J Radiat Oncol Biol Phys. 1992;22(3):459-62.
Charlier N, Beghein N, Gallez B Development and evaluation of biocompatible inks for the local measurement of oxygen using in vivo EPR. NMR Biomed. 2004 Aug;17(5):303-10.
Flood AB, Satinsky VA, Swartz HM Comparing the Effectiveness of Methods to Measure Oxygen in Tissues for Prognosis and Treatment of Cancer. Adv Exp Med Biol. 2016;923:113-120. doi: 10.1007/978-3-319-38810-6_15. Review.
Gallez B, Baudelet C, Jordan BF Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications. NMR Biomed. 2004 Aug;17(5):240-62. Review.
Hall EJ, Giaccia AJ Radiobiology for the Radiologist. Philadelphia: JB Lippincott. 1988.
Hees PS, Sotak CH Assessment of changes in murine tumor oxygenation in response to nicotinamide using 19F NMR relaxometry of a perfluorocarbon emulsion. Magn Reson Med. 1993 Mar;29(3):303-10. Erratum in: Magn Reson Med 1993 May;29(5):716.
Jordan BF, Baudelet C, Gallez B Carbon-centered radicals as oxygen sensors for in vivo electron paramagnetic resonance: screening for an optimal probe among commercially available charcoals. MAGMA. 1998 Dec;7(2):121-9.
Jordan BF, Misson P, Demeure R, Baudelet C, Beghein N, Gallez B Changes in tumor oxygenation/perfusion induced by the no donor, isosorbide dinitrate, in comparison with carbogen: monitoring by EPR and MRI. Int J Radiat Oncol Biol Phys. 2000 Sep 1;48(2):565-70.
Khan N, Grinberg O, Wilmot C, Kiefer H, Swartz HM "Distant spin trapping": a method for expanding the availability of spin trapping measurements. J Biochem Biophys Methods. 2005 Feb 28;62(2):125-30. Epub 2004 Nov 13.
Lartigau E, Lusinchi A, Eschwege F, Guichard M Tumor oxygenation: the Institut Gustave Roussy experience. In: Vaupel P, Kelleher DK (ed). Tumor hypoxia pathophysiology, clinical significance and therapeutic perspectives. Stuttgart, Germany: Wissenschaftliche Verlagsgesellschaft mbH. 1999:47-52.
O'Hara JA, Goda F, Demidenko E, Swartz HM Effect on regrowth delay in a murine tumor of scheduling split-dose irradiation based on direct pO2 measurements by electron paramagnetic resonance oximetry. Radiat Res. 1998 Nov;150(5):549-56.
O'Hara JA, Hou H, Demidenko E, Springett RJ, Khan N, Swartz HM Simultaneous measurement of rat brain cortex PtO2 using EPR oximetry and a fluorescence fiber-optic sensor during normoxia and hyperoxia. Physiol Meas. 2005 Jun;26(3):203-13. Epub 2005 Feb 25.
Smirnov AI, Norby SW, Walczak T, Liu KJ, Swartz HM Physical and instrumental considerations in the use of lithium phthalocyanine for measurements of the concentration of the oxygen. J Magn Reson B. 1994 Feb;103(2):95-102.
Swartz HM, Clarkson RB The measurement of oxygen in vivo using EPR techniques. Phys Med Biol. 1998 Jul;43(7):1957-75. Review.
Swartz HM, Dunn JF Measurements of oxygen in tissues: overview and perspectives on methods. Adv Exp Med Biol. 2003;530:1-12. Review.
Swartz HM, Halpern H EPR studies of living animals and related model systems (in vivo EPR). InBiological magnetic resonance 2002 (pp. 367-404). Springer US.
Swartz HM, Williams BB, Jarvis LA, Zaki BI, Gladstone DJ Repeated monitoring of tumor oxygen while breathing carbogen to determine the therapeutic potential of hyperoxic therapy. Pract Radiat Oncol. 2013 Apr-Jun;3(2 Suppl 1):S23-4. doi: 10.1016/j.prro.2013.01.084. Epub 2013 Mar 25.
Swartz HM EPR Studies of Cells and Tissue. In: Foundations Of Modern EPR 1998 (pp. 451-459).
Swartz HM Potential Medical (Clinical) Applications of EPR: Overview & Perspectives. InIn Vivo EPR (ESR) 2003 (pp. 599-621). Springer US.
Swartz HM Using EPR to measure a critical but often unmeasured component of oxidative damage: oxygen. Antioxid Redox Signal. 2004 Jun;6(3):677-86. Review.
Swartz, HM, N Khan, B.B. Williams, A.C. Hartford, B. Zaki, M. Ernstoff, J.C. Buckey, F.F. Gubaidullin, H. Hou, P. Lesniewski, M. Kmiec, O.Y. Grinberg, A. Sucheta, and T. Walczak, Clinical Applications of In Vivo EPR: EPR Oximetry in Treasures of Eureka, Electron Paramagnetic Resonance From Fundamental Research To Pioneering Applications & Zavoisky Award, Volume 1, Axas Publishing, New Zealand, pp. 178-179 (2009).
Swartz, HM, R P. Mason, N. Hogg, B. Kalyanaraman, T. Sarna, P.M. Plonka, M. Zareb, P.L. Gutierrez, and L.J. Berliner, Free Radicals and Medicine, in Biomedical ESR a volume in the Biological Magnetic Resonance Series (S.S. Eaton, G.R. Eaton, L.J. Berliner, eds.), Kluwer Publisher (The Netherlands, New York, Boston), Chapter 3, pp. 25-74 (2004a).
Vaupel P, Höckel M, Mayer A Detection and characterization of tumor hypoxia using pO2 histography. Antioxid Redox Signal. 2007 Aug;9(8):1221-35. Review.
Vaupel P Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol. 2004 Jul;14(3):198-206. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.